Hyperuricemia is Associated with Immunoglobulin G


Journal

Omics : a journal of integrative biology
ISSN: 1557-8100
Titre abrégé: OMICS
Pays: United States
ID NLM: 101131135

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 6 3 2019
medline: 9 6 2020
entrez: 6 3 2019
Statut: ppublish

Résumé

The increasing prevalence of hyperuricemia has been recognized as an emerging public health concern in both developed and developing countries. Hyperuricemia is a metabolic condition characterized by an elevated serum uric acid, and associated with renal damage, diabetes, autoimmune disorders, and cardiovascular diseases. Although human genetic variation has been recognized as a factor, posttranslational cellular processes and glycan biomarkers have not been studied extensively for susceptibility to hyperuricemia. We evaluated whether immunoglobulin (Ig)G

Identifiants

pubmed: 30835642
doi: 10.1089/omi.2019.0004
doi:

Substances chimiques

Biomarkers 0
Immunoglobulin G 0
Polysaccharides 0
glycosylated IgG 0
Uric Acid 268B43MJ25

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

660-667

Auteurs

Haifeng Hou (H)

School of Public Health, Taishan Medical University, Taian, China.

Xizhu Xu (X)

School of Public Health, Taishan Medical University, Taian, China.

Fengjing Sun (F)

Taishan Hospital of Shandong Province, Taian, China.

Xiaoyu Zhang (X)

Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.

Hualei Dong (H)

Taishan Hospital of Shandong Province, Taian, China.

Liang Wang (L)

Department of Bioinformatics, School of Medical Informatics, Xuzhou Medical University, Xuzhou, China.
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, China.

Siqi Ge (S)

Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

Kang An (K)

School of Public Health, Taishan Medical University, Taian, China.

Qi Sun (Q)

Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.

Yuejin Li (Y)

School of Public Health, Taishan Medical University, Taian, China.

Weijie Cao (W)

Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.

Manshu Song (M)

Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.

Shuangjie Hu (S)

Clinical Laboratory, Lianyungang Municipal Oriental Hospital, Lianyungang, China.

Weijia Xing (W)

School of Public Health, Taishan Medical University, Taian, China.

Wei Wang (W)

School of Public Health, Taishan Medical University, Taian, China.
Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.

Dong Li (D)

School of Public Health, Taishan Medical University, Taian, China.

Youxin Wang (Y)

Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH